Cardiovascular Diseases Clinical Trial
— VWCROfficial title:
Virtual World-Based Cardiac Rehabilitation to Improve Cardiovascular Health and Outcomes Among Cardiac Patients
The proposed trial is a multiphase, multicenter, non-inferiority, hybrid type 1 effectiveness, randomized controlled trial to test an innovative virtual world-based cardiac rehabilitation (CR) program, "Destination Cardiac Rehab". The primary objectives of this study are to assess the efficacy and adherence of "Destination Cardiac Rehab" compared to traditional center-based CR.
Status | Not yet recruiting |
Enrollment | 150 |
Est. completion date | September 1, 2028 |
Est. primary completion date | September 1, 2027 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Indication for CR according to Centers for Medicare & Medicaid Services (CMS) guidelines: Myocardial infarction within the preceding 12 months; Coronary artery bypass surgery; Current stable angina (chest pain); Heart valve repair or replacement; Percutaneous transluminal coronary angioplasty (PTCA) or coronary stenting; Heart or heart-lung transplant; Stable chronic heart failure - Aged =18 years - Basic Internet navigation skills - Active email address Exclusion Criteria: - High risk patients according to the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) risk stratification (e.g., sudden cardiac arrest survivor) - Receiving continuous inotropic support - Presence of a mechanical circulatory support device - Decompensated heart failure - Symptomatic valvular heart disease - Uncontrolled angina - Presence of hemodynamically unstable dysrhythmias (e.g., ventricular tachycardia) given safety concern of unsupervised exercise20 - Pregnant (due to associated hormonal and weight changes) - Non-English-speaking - Visual/hearing impairment or mental disability that would preclude independent use of the VW platform |
Country | Name | City | State |
---|---|---|---|
United States | Mayo Clinic | Rochester | Minnesota |
Lead Sponsor | Collaborator |
---|---|
Mayo Clinic | Johns Hopkins University, University of California, Irvine, University of Mississippi Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Life's Essential 8 component: Self-reported healthy diet | Changes from baseline in healthy diet using the Mediterranean Eating Patterns for Americans (MEPA), a 16-item questionnaire evaluating accordance with a Mediterranean-like diet pattern | Baseline, 3 months, and 6 months post-randomization | |
Primary | Life's Essential 8 component: Self-reported physical activity | Changes from baseline in physical activity using the International Physical Activity Questionnaire (IPAQ), a 12-item questionnaire classifying physical activity as "low," "moderate," or "high" intensity physical activity (minutes/day) over the prior week | Baseline, 3 months, and 6 months post-randomization | |
Primary | Life's Essential 8 component: Self-Reported smoking status | Changes from baseline in smoking status using the National Health and Nutrition Examination Survey-Smoking-Cigarette Use Questionnaire (NHANES-SMQ), evaluating current and past smoking habits | Baseline, 3 months, and 6 months post-randomization | |
Primary | Life's Essential 8 component: Sleep Quality | Changes from baseline in sleep quality (number of hours of sleep nightly) using the Pittsburg Sleep Quality Index (PSQI). | Baseline, 3 months, and 6 months post-randomization | |
Primary | Life's Essential 8 component: Body Mass Index (BMI) | Changes from baseline in BMI as calculated with weight (kg) and height (m), reported as kg/m^2 | Baseline, 3 months, and 6 months post-randomization | |
Primary | Life's Essential 8 component: Cholesterol | Changes from baseline in Non-HDL Cholesterol levels reported as mg/dL | Baseline, 3 months, and 6 months post-randomization | |
Primary | Life's Essential 8 component: Blood Glucose | Changes from baseline in Hemoglobin A1c (percent) and fasting blood glucose (mg/dL) | Baseline, 3 months, and 6 months post-randomization | |
Primary | Life's Essential 8 component: Blood Pressure | Changes from baseline in systolic and diastolic blood pressure measurements; average of three sitting readings in mmHg | Baseline, 3 months, and 6 months post-randomization | |
Primary | Life's Essential 8 composite score: Cardiovascular health | Changes from baseline in Life's Essential 8 score. Life's Essential 8 composite score is determined as a composite of all components by calculating an unweighted average score on a scale of 0 to 100 points. An overall cardiovascular health score (Life's Essential 8 score) will be considered high (80 to 100 points), moderate (50 to 79 points) or low for (0 to 49 points). | Baseline, 3 months, and 6 months post-randomization | |
Primary | Number of sessions attended by participants | Optimal adherence defined as completion of 70% or more of weekly visits (in-person or virtual). Attendance measured by CR staff for control group, and by VWCR web administrators, Exercise Physiologists, and Nurse Coaches in the VWCR arm. | Baseline through 12-week program | |
Secondary | MACE (Major Adverse Cardiovascular Events) 3 months post-randomization | MACE (Major Adverse Cardiovascular Events): CV-related hospital readmissions; CV and all-cause mortality | 3 months and 6 months post-randomization | |
Secondary | Exercise Sessions | Self-reported number of self-directed exercise sessions per week, confirmed by Fitbit activity tracker data. | Baseline through 12-week (36 session) cardiac rehabilitation program | |
Secondary | Functional Capacity | Six-Minute walk test, evaluating blood pressure, oxygen saturation, and pulse after walking for 6 minutes at a normal pace | Baseline, 3 months, and 6 months post-randomization | |
Secondary | Health-related quality of life | Changes from baseline in health-related quality of life using the Short Form [SF]-12 Health Survey, a self-reported outcome measure assessing the impact of health on an individual's everyday life. The SF-12 consists of 12-items and 8 subdomains. Each item of the questionnaire has response categories which vary from 2- to 6-point scales and raw scores for items ranging from 1 to 6. The raw scores are summated and linearly transformed into 0-100 scale with a higher score indicating better health status. | Baseline, 3 months, and 6 months post-randomization | |
Secondary | Physical Activity Self-efficacy | Changes from baseline in physical activity self-efficacy measured by the Exercise Confidence Survey scale to assess the participant's confidence in their ability to exercise when faced with common barriers. 12 items are assessed, each on a 5-point scale ranging from 1 to 5. A higher total sum indicates higher self-efficacy for physical activity. | Baseline, 3 months, and 6 months post-randomization | |
Secondary | Physical Activity Self-regulation | Changes from baseline in physical activity self-regulation measured by the Health Beliefs Survey to assess strategies used in the past 3 months to increase their step count or physical activity levels. Items are measured on a five-point scale from 1 (never) to 5 (repeatedly). Higher scores indicate more self-regulation. | Baseline, 3 months, and 6 months post-randomization | |
Secondary | Physical Activity Social Support | Changes from baseline in physical activity social support using the Social Support for Exercise Survey scale that asks participants how much encouragement they received to increase physical activity on a five-point scale from 1 (never) to 5 (very often). Higher scores indicate more social support for physical activity. | Baseline, 3 months, and 6 months post-randomization | |
Secondary | Diet Self-efficacy | Changes from baseline in diet self-efficacy measured the Diet Confidence Survey scale to assess the participant's confidence in their ability to maintain a healthy diet when faced with common barriers. 12 items are assessed, each on a 5-point scale ranging from 1 to 5. A higher total sum indicates higher self-efficacy for healthy eating. | Baseline, 3 months, and 6 months post-randomization | |
Secondary | Diet Self-regulation | Changes from baseline in diet self-regulation measured by the Health Beliefs Survey to assess strategies used in the past 3 months to eat healthier foods. Items are measured on a five-point scale from 1 (never) to 5 (repeatedly). Higher scores indicate more use of self-regulation strategies to promote healthy eating. | Baseline, 3 months, and 6 months post-randomization | |
Secondary | Diet Social Support | Changes from baseline in diet social support using the Social Support for Eating Habits Survey scale that asks participants how much encouragement they received to eat healthier on a five-point scale from 1 (never) to 5 (very often). Higher scores indicate more social support for healthy eating. | Baseline, 3 months, and 6 months post-randomization |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|